Core Viewpoint - The stock of Precision Medical-B (02675) surged over 12% following the release of a new surgical robot pricing guideline by the National Healthcare Security Administration, indicating strong market potential for the surgical robot industry in China and globally [1] Industry Summary - The surgical robot industry is experiencing rapid growth driven by technological innovation, clinical demand, and favorable policies, particularly in the single-port and natural orifice robot segments in China [1] - Analysts recommend focusing on domestic surgical robot manufacturers for import substitution and international expansion opportunities [1] Company Summary - Precision Medical's multi-port laparoscopic surgical robot was commercialized in December 2022, and by 2024, the company sold 20 units in China, ranking first among domestic manufacturers [1] - The company is set to accelerate its international expansion starting in 2025, with a significant increase in overseas orders; as of the end of 2025, 72 out of 118 global sales agreements for core products are with foreign countries [1]